ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2571

Trajectories of Physical Function in Children with Juvenile Idiopathic Arthritis: Results from the CAPRI Registry

Clare Cunningham1, Roberta A Berard2, Matthew Berkowitz3, Brian Feldman4, Nicole Johnson5, Lillian Lim6, Thomas Loughin3, Meghan McPherson7, Paivi Miettunen5, Jean-Philippe Proulx-Gauthier8, Dax Rumsey6, Heinrike Schmeling5, Lori Tucker9, Kristin Houghton10 and Jaime Guzman11, and CAPRI Registry Investigators, 1University of British Columbia, Vancouver, BC, Canada, 2London Health Sciences Centre, London, ON, Canada, 3Simon Fraser University, Burnaby, BC, Canada, 4Division of Rheumatology, The Hospital for Sick Children; Departments of Pediatrics and Medicine, Faculty of Medicine; The Institute for Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada, 5University of Calgary, Calgary, AB, Canada, 6University of Alberta, Edmonton, AB, Canada, 7University of Manitoba, Winnipeg, MB, Canada, 8CHU de Quebec - Universite Laval, Quebec, QC, Canada, 9BC Children's Hospital, Vancouver, BC, Canada, 10University of British Columbia - Vancouver, Vancouver, BC, Canada, 11University of British Columbia and BC Children's Hospital, Vancouver, BC, Canada

Meeting: ACR Convergence 2024

Keywords: Juvenile idiopathic arthritis, longitudinal studies, physical function

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 18, 2024

Title: Abstracts: Pediatric Rheumatology – Clinical I

Session Type: Abstract Session

Session Time: 1:00PM-2:30PM

Background/Purpose: Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease of childhood. Contrary to historical cohorts, it is hoped that with contemporary treatments most children with JIA will quickly improve in physical function. However, little is known about the long-term trajectories of physical function across the seven JIA categories, and the impact of age, sex, and number of active joints. The aim of this study was to describe these trajectories during the first three years following diagnosis and assess factors that may influence them.

Methods: We included children recruited within 3 months of JIA diagnosis in the Canadian Alliance of Pediatric Rheumatology Investigators (CAPRI) Registry whose parents completed at least 2 functional assessments between February 2017 and April 2024. Physical function was assessed using the Kids Disability Screen (KDS); the mean of numerical answers to 2 questions: “Does your child usually need help from you or another person because of arthritis?” and “Is it hard for your child to run and play because of arthritis?” This screen is scored from 0=no disability to 10=severe disability and has been shown to be comparable to a full Childhood Health Assessment Questionnaire (CHAQ) disability index1. Data was analyzed with descriptive statistics and mean trajectories were charted using LOWESS estimated with a bandwidth of 0.8.

Results: Out of a total of 1,137 children recruited within 3 months of diagnosis in the registry, 940 patients (82.6%) provided at least 2 physical function assessments for a total of 7,351 assessments, 6,088 of which occurred within 3 years of diagnosis. Most children had oligoarthritis (n=426, 45.3%), polyarthritis RF-negative (n=181, 19.3%) or enthesitis-related arthritis (ERA) (n=135, 14.4%). The median age at diagnosis was 9.1 years (IQR 4.3, 13.2) and 587 (63.2%) were female (Table 1). Trajectories varied across JIA categories. Polyarthritis RF-positive had the highest mean KDS score upon diagnosis, and psoriatic arthritis had the lowest. LOWESS indicated that KDS scores improved for all categories over time (Figure 1). At 3 years follow up, children with ERA and systemic JIA seemed to have higher mean KDS scores than the other categories. Although all trajectories showed improvement over time, no category reached a mean of 0, and some individuals in each category still had KDS scores >4 within the 3rd year (Figure 2). Higher active joint counts at diagnosis and female sex appeared to be associated with higher mean KDS scores until weeks 80 and 140 respectively. Age at diagnosis did not appear to have a consistent relationship with mean KDS scores.

Conclusion: JIA categories that start at different levels of functional impairment all show improvement over time, but a subset of children continue to report functional deficits well into their disease course. On average, females, and patients with higher active joint count at baseline report higher levels of disability. Further identification of the population experiencing persisting functional deficits will be important to improve the overall outcomes of JIA.

Funded by The Arthritis Society and The Canadian Institute of Health Research.

1 Houghton K, et al. Rheumatology. 2022;61(12):4835–44.

Supporting image 1

Table 1: Baseline characteristics of cohort at enrollment

Supporting image 2

Fig. 1: Trajectories of physical function by JIA category. LOWESS curves estimated with bandwidth 0.8 for each of the seven JIA categories by Kids Disability Screen (KDS) scores during the first three years after diagnosis.

Supporting image 3

Fig. 2: Trajectories of physical function by JIA category and their corresponding KDS score dispersions. LOWESS curves estimated with bandwidth 0.8 and corresponding scatterplots for categories by Kids Disability Screen (KDS) scores during the first 3 years after date of diagnosis


Disclosures: C. Cunningham: None; R. Berard: AbbVie/Abbott, 1, Sandoz, 1; M. Berkowitz: None; B. Feldman: None; N. Johnson: AbbVie/Abbott, 6, Pfizer, 6; L. Lim: None; T. Loughin: None; M. McPherson: None; P. Miettunen: None; J. Proulx-Gauthier: None; D. Rumsey: None; H. Schmeling: AbbVie/Abbott, 5, Bristol-Myers Squibb(BMS), 5, Janssen, 5, Pfizer, 5, UCB, 5; L. Tucker: None; K. Houghton: None; J. Guzman: None.

To cite this abstract in AMA style:

Cunningham C, Berard R, Berkowitz M, Feldman B, Johnson N, Lim L, Loughin T, McPherson M, Miettunen P, Proulx-Gauthier J, Rumsey D, Schmeling H, Tucker L, Houghton K, Guzman J. Trajectories of Physical Function in Children with Juvenile Idiopathic Arthritis: Results from the CAPRI Registry [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/trajectories-of-physical-function-in-children-with-juvenile-idiopathic-arthritis-results-from-the-capri-registry/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/trajectories-of-physical-function-in-children-with-juvenile-idiopathic-arthritis-results-from-the-capri-registry/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology